Does Dr. NATALIO IZQUIERDO ENCARNACION have financial conflicts of interest?

Dr. NATALIO IZQUIERDO ENCARNACION (MD) has received a total of $15,780 in pharmaceutical and medical device industry funding between 2021 and 2025. This includes $15,780 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. NATALIO IZQUIERDO ENCARNACION?

According to CMS Open Payments data, Dr. NATALIO IZQUIERDO ENCARNACION received funding from RHYTHM PHARMACEUTICALS ($15,188), AMGEN ($160), and BAUSCH & LOMB AMERICAS ($118).

Does Dr. NATALIO IZQUIERDO ENCARNACION receive research grants or speaking fees?

Dr. NATALIO IZQUIERDO ENCARNACION has received $15,780 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. NATALIO IZQUIERDO ENCARNACION

MDReal-Time Hydrated

Specialty: Ophthalmology

Practice Location: SAN JUAN, PR 00923

NPI Number: 1982652772

LIFETIME INDUSTRY VALUE

$15,780

2021 – 2025 Cumulative

Conflict of Interest Analysis

Dr. IZQUIERDO ENCARNACION is a verified Ophthalmology practitioner based in SAN JUAN, PR.

Between 2021 and 2025, Dr. IZQUIERDO ENCARNACION had an overall industry promotional and research financial footprint of $15,780 as recorded in the federal CMS Open Payments database.

$15,780 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. IZQUIERDO ENCARNACION's primary funding source is RHYTHM PHARMACEUTICALS, which accounts for $15,188 (representing 96.3% of overall industry footprint).

Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

RHYTHM PHARMACEUTICALS

Rank 1

$15,188

96.3%

AMGEN

Rank 2

$160

BAUSCH & LOMB AMERICAS

Rank 3

$118

0.7%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2025

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.